AGLNYSEServices-Misc Health & Allied Services, NECFiscal year ends December 31
agilon health, inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$88.83+3.71 (+4.36%)
Close on Oct 19, 2026
- Market cap
- $1.53B
- P/E (TTM)
- –
- Dividend yield
- –
agilon health, inc. revenue by segment
By business segment
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|
| Medical services revenue | $5.92B | $6.05B | $4.31B | $2.38B | – | – | – | 99.8% | -2.1% |
| Other operating revenue | $11.24M | $12.82M | $9.01M | $3.33M | – | – | – | 0.2% | -12.3% |
| Other operating revenue | – | – | – | $3.82M | $3.82M | $4.06M | $5.85M | – | – |
| Medical services revenue | – | – | $4.31B | $2.38B | $1.52B | $1.21B | $788.57M | – | – |
| Other Operating | – | – | $9.01M | $3.33M | $3.17M | – | – | – | – |
By region
From the segment and revenue-disaggregation notes of agilon health's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.